Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer

Tomas Thiel, Charlotta Ryk, Lotta Renström-Koskela, Gunnar Steineck, Martin C. Schumacher, N. Peter Wiklund, Petra J. de Verdier

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences